NASDAQ | DRNA

$2.79 - 0.03 (-1.064%)

3 month stock price graph

4:00 PM ET on Jan 20, 2017 Pricing delayed 20 minutes

Investors & Media

Investors & Media

Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas.